scholarly article | Q13442814 |
P356 | DOI | 10.1007/S13277-014-2376-0 |
P698 | PubMed publication ID | 25077923 |
P2093 | author name string | Yu Yang | |
Cong-Chao Ma | |||
Sheng-Wen Wu | |||
P2860 | cites work | Over-expression of Her-2 in colorectal cancer tissue, but not in serum, constitutes an independent worse prognostic factor | Q86876904 |
Cancer statistics, 2010 | Q27860525 | ||
Measuring inconsistency in meta-analyses | Q27860655 | ||
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 | Q27860674 | ||
Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene | Q27860693 | ||
Cancer statistics, 2013 | Q27860762 | ||
Practical methods for incorporating summary time-to-event data into meta-analysis | Q28131754 | ||
Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer | Q29547699 | ||
ERBB receptors and cancer: the complexity of targeted inhibitors | Q29619520 | ||
Is overexpression of HER-2 a predictor of prognosis in colorectal cancer? | Q30856729 | ||
Colorectal cancer in Guangdong Province of China: a demographic and anatomic survey | Q33688323 | ||
Clinicopathological and prognostic significance of HER-2/neu and VEGF expression in colon carcinomas | Q33943812 | ||
Her-2/neu and breast cancer | Q34365892 | ||
Prognostic role of CD133 expression in colorectal cancer: a meta-analysis | Q34502600 | ||
Much ado about nothing: a comparison of the performance of meta-analytical methods with rare events. | Q34510811 | ||
Prognostic value of CD166 expression in cancers of the digestive system: a systematic review and meta-analysis | Q34936453 | ||
Adjuvant trastuzumab in HER2-positive breast cancer | Q35710898 | ||
Amplification of the c-erbB-2 (HER-2/neu) gene in gastric cancer cells. Detection by fluorescence in situ hybridization | Q35763518 | ||
c-erbB-2 is not a major factor in the development of colorectal cancer | Q36644043 | ||
The ErbB signalling pathway: protein expression and prognostic value in epithelial ovarian cancer | Q36785983 | ||
The expression of multiple proteins as prognostic factors in colorectal cancer: cathepsin D, p53, COX-2, epidermal growth factor receptor, C-erbB-2, and Ki-67 | Q37564008 | ||
Promoter CpG island methylation markers in colorectal cancer: the road ahead | Q37997086 | ||
HER-2/neu overexpression is an independent prognostic factor in colorectal cancer. | Q40291966 | ||
Prognostic significance of p53 and c-erbB-2 immunohistochemical evaluation in colorectal adenocarcinoma | Q40981286 | ||
Targeted HER2 treatment in advanced gastric cancer | Q43148962 | ||
ErbB family immunohistochemical expression in colorectal cancer patients with higher risk of recurrence after radical surgery. | Q47950050 | ||
Clinical role of HER-2/neu expression in colorectal cancer. | Q51046708 | ||
Frequency of HER-2 positivity in rectal cancer and prognosis. | Q51283402 | ||
Prognostic significance of c-erbB-2 and vascular endothelial growth factor in colorectal liver metastases. | Q51789617 | ||
Clinico-Pathological and Prognostic Significance of p53, Bcl-2 and Her-2/neu Protein Markers in Colorectal Cancer Using Tissue Microarray. | Q53317073 | ||
Assessment of staging, prognosis and mortality of colorectal cancer by tumor markers: receptor erbB-2 and cadherins. | Q53648066 | ||
Expression of EGFR, Her2 predict lymph node metastasis (LNM)-associated metastasis in colorectal cancer. | Q54280357 | ||
Serum levels of HER-2 neu (C-erbB-2) correlate with overexpression of p185neu in human ovarian cancer | Q72221452 | ||
The prognostic value of invariant chain (Ii) and Her-2/neu expression in curatively resected colorectal cancer | Q74325369 | ||
Immunohistochemical study of c-erbB-2 protein in colorectal cancer and the correlation with patient survival | Q77432075 | ||
P433 | issue | 11 | |
P921 | main subject | colorectal cancer | Q188874 |
overexpression | Q61643320 | ||
P304 | page(s) | 10799-10804 | |
P577 | publication date | 2014-07-31 | |
P1433 | published in | Tumor Biology | Q15757842 |
P1476 | title | The prognostic value of HER-2/neu overexpression in colorectal cancer: evidence from 16 studies. | |
P478 | volume | 35 |
Q40212670 | Association of HER2 codon 655 polymorphism with ovarian cancer |
Q26801167 | Correlation of human epidermal growth factor receptor protein expression and colorectal cancer |
Q35651481 | Expression of COX-2 and HER-2 in colorectal cancer and their correlation |
Q36020920 | HER-2 and HER-3 expression in liver metastases of patients with colorectal cancer. |
Q28078111 | HER2 aberrations and heterogeneity in cancers of the digestive system: Implications for pathologists and gastroenterologists |
Q35029025 | HER2 expression in gastric and oesophageal cancer: a meta-analytic review |
Search more.